4
Changes in Ownership
SAB Biotherapeutics, Inc. Filed Acc 0000950170-24-121563
Options or other derivatives
- Director acquired 55,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Ellias Helen K. Director | 2024-11-01 | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | D: show line 1 in the form | |||||
| Ellias Helen K. Director | 2024-11-01 | Grant or award · Stock Option (right to buy) | +35,000 | 35,000 | D: show line 2 in the form |
Loading xslF345X05/ownership.xml…